| ²é¿´: 157 | »Ø¸´: 5 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
muerntľ³æ (СÓÐÃûÆø)
|
[½»Á÷]
ÇóÖú
|
||
|
Âé·³ÄÄλ´ó¸ç°ïæ×öÒ»ÏÂлл£¡£¡ ÇëÀûÓÃGoogleѧÊõËÑË÷¡¾http://scholar.google.cn/¡¿²éѯ¡¶Öлª»¤ÀíÔÓÖ¾¡·ÉÏÓйء°»¤Àíѧ¡±µÄÎÄÕ£¬ÒªÇóժ¼ÆäÖÐÒ»Ìõ½á¹ûµÄÍøÒ³±êÌâºÍÄÚÈÝÕªÒª£¬Ð´³ö¸ÃƪÎÄÕ±»ÒýÓõĴÎÊý£¬²¢ÁгöÒ»µ½Á½ÆªÒýÎÄ¡££¨±¾Ìâ10·Ö£© Îå¡¢ÇëÀûÓÃPubMed¼ìË÷ϵͳµÄ»ù±¾¼ìË÷¹¦ÄÜÍê³É¡°liver cancer¡±µÄ¼ìË÷£¬´ò¿ªÒ»ÆªÃâ·ÑÈ«ÎÄÔĶÁ£¨Í¼±êΪ free full text£©£¬¸´ÖÆÆäÌâ¼¼°µÚһС½Ú¡¾http://www.ncbi.nlm.nih.gov/sites/entrez/¡¿¡££¨±¾Ìâ10·Ö£© Âé·³ÄÄλ´ó¸ç°ïæ×öһϠ|
» ²ÂÄãϲ»¶
384Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ÉúÎïѧѧ˶Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
081700 µ÷¼Á 267·Ö
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ0817»¯¹¤278·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
269Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸211 ³õÊÔ270·Ö Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏרҵÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
muernt
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2268.1
- Ìû×Ó: 189
- ÔÚÏß: 46.7Сʱ
- ³æºÅ: 655755
- ×¢²á: 2008-11-16
- ÐÔ±ð: MM
- רҵ: ¼ÆËã»úÈí¼þ
|
ѧÊõ¸ß¼¶ËÑË÷ ¸ß¼¶ËÑË÷¼¼ÇÉ | ¹ØÓÚ Google ѧÊõËÑË÷ ²éÕÒÎÄÕ °üº¬È«²¿×Ö´Ê 10 Ïî½á¹û20 Ïî½á¹û30 Ïî½á¹û50 Ïî½á¹û100 Ïî½á¹û °üº¬È·ÇеĴÊÓï °üº¬ÖÁÉÙÒ»¸ö×Ö´Ê ²»°üº¬×Ö´Ê ³öÏÖËÑË÷×Ö´ÊλÖà ÎÄÕÂÖÐÈκÎλÖÃλÓÚÎÄÕ±êÌâ ×÷Õß ÏÔʾÒÔÏÂ×÷ÕßËùÖøÎÄÕ ÀýÈ磺¶¡ÕØÖÐ »ò "PJ Hayes" ³ö°æÎï ÏÔʾÒÔÏ¿¯ÎïÉϵÄÎÄÕ ÀýÈ磺¡¶Ñ§Êõ̽Ë÷¡·»ò¡¶Nature¡· ÈÕÆÚ ÏÔʾÔÚ´ËÆÚ¼ä¿¯µÇµÄÎÄÕ ¡ª ÀýÈ磺1996 ÉϲéÁË£¬µÃµ½µÄ²»ÊÇÖлª»¤ÀíÔÓÖ¾µÄµÄÎÄÕ |
5Â¥2008-11-21 20:14:19
zhangquee
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
°®»¨²»²É»¨£¬äìÈ÷²»ÂÒÈ÷£¡
- LS-EPI: 4
- Ó¦Öú: 38 (СѧÉú)
- ¹ó±ö: 4.19
- ½ð±Ò: 29596.7
- É¢½ð: 4948
- ºì»¨: 15
- Ìû×Ó: 14985
- ÔÚÏß: 305.2Сʱ
- ³æºÅ: 87851
- ×¢²á: 2005-08-21
- ÐÔ±ð: GG

2Â¥2008-11-21 19:45:12
muernt
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2268.1
- Ìû×Ó: 189
- ÔÚÏß: 46.7Сʱ
- ³æºÅ: 655755
- ×¢²á: 2008-11-16
- ÐÔ±ð: MM
- רҵ: ¼ÆËã»úÈí¼þ
3Â¥2008-11-21 19:51:12
muernt
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2268.1
- Ìû×Ó: 189
- ÔÚÏß: 46.7Сʱ
- ³æºÅ: 655755
- ×¢²á: 2008-11-16
- ÐÔ±ð: MM
- רҵ: ¼ÆËã»úÈí¼þ
ÕâÊDz»ÊǵڶþÌõµÄ´ð°¸°¡
|
1: Oncogene. 2008 Nov 17. [Epub ahead of print] ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Lahsnig C, Mikula M, Petz M, Zulehner G, Schneller D, van Zijl F, Huber H, Csiszar A, Beug H, Mikulits W. 1Division: Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Borschke-Gasse 8a, Vienna, Austria. In human hepatocellular carcinoma (HCC), epithelial to mesenchymal transition (EMT) correlates with aggressiveness of tumors and poor survival. We employed a model of EMT based on immortalized p19(ARF) null hepatocytes (MIM), which display tumor growth upon expression of oncogenic Ras and undergo EMT through the |
4Â¥2008-11-21 20:05:43













»Ø¸´´ËÂ¥